Form 4 Tracker
Jeffrey M. Dayno

Director, PRESIDENT, CEO · 1 filing · Latest: Jan 22, 2026

Harmony Biosciences Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
HRMY
Jeffrey M. DaynoDirector, PRESIDENT, CEOJan 25, 2026
Option Exercise
$0.0013,00013,000
HRMY
Jeffrey M. DaynoDirector, PRESIDENT, CEOJan 24, 2026
Option Exercise
$0.0010,50010,500
HRMY
JEFFREY M DAYNODec 12, 2025
Proposed Sale
$39.5925,933$1.0M
HRMY
JEFFREY M DAYNOJan 21, 2025
Proposed Sale
$39.0519,293$753.4K